Researcher.Life Logo

Expert Review of Anti-Infective Therapy : Impact Factor & More

eISSN: 1744-8336pISSN: 1478-7210

Aims and Scope of Expert Review of Anti-Infective Therapy

Expert Review of Anti-infective Therapy is a monthly peer-reviewed medical journal publishing review articles and original papers on all aspects of anti-infective therapy. The journal was established in 2003 and is published by Informa. Less

Key Metrics

CiteScore
7.7
Eigenfactor
0.005 - 0.01
H-Index
89
Impact Factor
5 - 10
SJR
Q1Virology
SNIP
1.4
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Expert Review of Anti-Infective Therapy

Expert Review of Anti-Infective Therapy Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher TAYLOR & FRANCIS LTD
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2003
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Expert Review of Anti-Infective Therapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Expert Review of Anti-Infective Therapy

Pneumocystis pneumonia in non-HIV immunocompromised patients in 2026: evolving therapeutic standards.
  • 29 Jun 2026
  • Expert review of anti-infective therapy
The endocarditis team: a review
  • 27 Jun 2026
  • Expert Review of Anti-infective Therapy
Asymptomatic is not silent: proposal of HTLV-1–associated multiple inflammatory disease as an early neuroinflammatory state
  • 27 Jun 2026
  • Expert Review of Anti-infective Therapy
Anti-infective therapy and novel treatment options for coccidioidomycosis
  • 27 Jun 2026
  • Expert Review of Anti-infective Therapy
The impact of sex on therapy, epidemiology, and outcome in bloodstream infections
  • 26 Jun 2026
  • Expert Review of Anti-infective Therapy
Synergistic antifungal effects and potential mechanisms of crisaborole combined with azoles against drug-resistant Candida albicans
  • 25 Jun 2026
  • Expert Review of Anti-infective Therapy
Pneumocystis pneumonia in non-HIV immunocompromised patients in 2026: evolving therapeutic standards.
  • 29 Jun 2026
  • Expert review of anti-infective therapy
The endocarditis team: a review
  • 27 Jun 2026
  • Expert Review of Anti-infective Therapy
Asymptomatic is not silent: proposal of HTLV-1–associated multiple inflammatory disease as an early neuroinflammatory state
  • 27 Jun 2026
  • Expert Review of Anti-infective Therapy
Anti-infective therapy and novel treatment options for coccidioidomycosis
  • 27 Jun 2026
  • Expert Review of Anti-infective Therapy
The impact of sex on therapy, epidemiology, and outcome in bloodstream infections
  • 26 Jun 2026
  • Expert Review of Anti-infective Therapy
Synergistic antifungal effects and potential mechanisms of crisaborole combined with azoles against drug-resistant Candida albicans
  • 25 Jun 2026
  • Expert Review of Anti-infective Therapy

FAQs on Expert Review of Anti-Infective Therapy